⌘K

16:35:14·69d

SECFilingvia Quantisnow

Amendment: SEC Form SCHEDULE 13G/A filed by LB Pharmaceuticals Inc

ByQuantisnow·Wall Street's wire, on your screen.

LBRX· LB Pharmaceuticals Inc

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

LBRX
LB Pharmaceuticals Inc
Health Care

Recent analyst ratings

Apr 27UpdateH.C. Wainwright$45.00
Apr 10UpdateCraig Hallum$36.00
Jan 9UpdateRoth Capital-
Oct 6UpdateStifel$27.00
Oct 6UpdatePiper Sandler$78.00
Oct 6UpdateLeerink Partners$34.00

Related

ANALYST1d
H.C. Wainwright initiated coverage on LB Pharmaceuticals with a new price target
SEC4d
SEC Form DEFA14A filed by LB Pharmaceuticals Inc
SEC4d
SEC Form DEF 14A filed by LB Pharmaceuticals Inc
PR5d
LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
SEC13d
SEC Form EFFECT filed by LB Pharmaceuticals Inc
SEC13d
SEC Form 424B3 filed by LB Pharmaceuticals Inc
ANALYST18d
Craig Hallum initiated coverage on LB Pharmaceuticals with a new price target
PR18d
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference